NYSEARCA:LCTX

Lineage Cell Therapeutics Stock Predictions

etoro logo Buy LCTX
*Your capital is at risk
$1.20
-0.0100 (-0.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

LCTX Prediction Chart

LCTX Predictions History

Latest community submissions for LCTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 7, 2025 Bullish $0.95 X 0
Jun 17, 2025 Bullish $0.86 X 0
Jan 4, 2022 Bullish $2.27 X 0
JS JS Pro
Jan 3, 2022 $2.41 -2.82% $2.48 X 97.18% 0
Jan 3, 2022 Bearish $2.48 X 0
Jan 3, 2022 Bullish $2.48 X 0
JS JS Pro
Feb 1, 2021 $2.24 -4.27% $2.34 X 95.73% 1
anthony Gomez anthony Gomez @anthonyGomez.195611
Feb 1, 2021 Bullish $2.34 X 1
JS JS Pro
Jan 22, 2021 $2.65 -0.38% $2.66 X 99.62% 5
tony karreci tony karreci @tonykarreci.181662
Jan 22, 2021 Bearish $2.66 X 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LCTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT LINEAGE CELL THERAPEUTICS, INC.
Lineage Cell Therapeutics
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa mul...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE